GT Biopharma (GTBP) Stock Chart & Stock Price History $2.94 -0.07 (-2.33%) (As of 10/31/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends GT Biopharma Stock Price Performance5 Day Performance-3.53%1 Month Performance+30.36%3 Month Performance+15.33%6 Month Performance+0.33%Year-To-Date Performance-60.65%1 Year Performance-59.93% Receive GTBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. GTBP Stock Chart for Thursday, October, 31, 2024 GTBP Chart by TradingView GT Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/30/2024$3.26$3.01-7.67%$3.30$3.0115,132 shs$4.27 million10/29/2024$3.30$3.26-1.21%$3.37$3.1015,742 shs$4.62 million10/28/2024$3.12$3.30+5.77%$3.30$3.0122,712 shs$4.68 million10/25/2024$3.08$3.12+1.30%$3.12$2.9243,960 shs$4.42 million10/24/2024$2.95$3.08+4.44%$3.55$2.8079,360 shs$4.36 million10/23/2024$2.54$2.95+16.11%$2.96$2.5445,134 shs$4.18 million Get the Latest News and Ratings for GTBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. 10/22/2024$2.42$2.54+4.96%$2.56$2.4239,513 shs$3.60 million10/21/2024$2.29$2.42+5.68%$2.58$2.2636,933 shs$3.43 million10/18/2024$2.11$2.26+7.11%$2.33$2.0422,473 shs$3.20 million10/17/2024$2.01$2.11+4.98%$2.11$2.0227,156 shs$2.99 million10/16/2024$1.99$2.01+1.01%$2.01$1.9716,932 shs$2.85 million10/15/2024$2.05$1.99-2.87%$2.05$1.958,659 shs$2.82 million10/14/2024$2.05$2.05-0.05%$2.05$2.004,598 shs$2.90 million10/11/2024$2.00$2.05+2.50%$2.08$2.0011,184 shs$4.57 million10/10/2024$2.07$2.00-3.38%$2.09$2.0011,961 shs$2.83 million10/09/2024$2.06$2.07+0.49%$2.18$2.0521,193 shs$2.93 million10/08/2024$2.07$2.06-0.24%$2.12$2.061,863 shs$2.92 million10/07/2024$2.02$2.07+2.23%$2.14$1.9711,425 shs$2.93 million10/04/2024$2.18$2.02-7.34%$2.18$1.9530,165 shs$2.86 million10/03/2024$2.15$2.18+1.40%$2.19$2.1011,174 shs$3.09 million10/02/2024$2.22$2.15-3.15%$2.19$2.0613,867 shs$3.05 million10/01/2024$2.31$2.22-3.85%$2.55$2.2024,098 shs$3.15 million09/30/2024$2.12$2.31+8.92%$2.80$2.1063,994 shs$3.27 million09/27/2024$2.09$2.12+1.44%$2.19$2.035,805 shs$3.00 million09/26/2024$2.05$2.09+1.95%$2.12$2.066,809 shs$4.66 million09/25/2024$2.00$2.05+2.50%$2.08$2.001,384 shs$4.57 million09/24/2024$1.97$2.00+1.52%$2.10$1.986,166 shs$2.83 million09/23/2024$2.05$1.97-3.90%$2.06$1.9213,117 shs$2.79 million09/20/2024$2.05$2.05$2.17$2.0514,461 shs$2.91 million09/19/2024$2.18$2.05-5.96%$2.18$2.0513,385 shs$2.91 million09/18/2024$2.19$2.18-0.46%$2.29$2.1313,301 shs$3.09 million09/17/2024$2.12$2.19+3.30%$2.29$2.126,308 shs$4.88 million09/16/2024$2.18$2.12-2.75%$2.24$2.0821,598 shs$4.73 million09/13/2024$2.15$2.17+1.17%$2.19$2.062,522 shs$4.84 million09/12/2024$2.12$2.15+1.18%$2.22$2.0616,680 shs$4.78 million09/11/2024$2.07$2.12+2.54%$2.14$2.055,075 shs$4.73 million09/10/2024$2.16$2.07-4.28%$2.14$2.071,901 shs$4.61 million09/09/2024$1.95$2.16+10.77%$2.23$1.959,755 shs$4.82 million09/06/2024$2.06$1.95-5.34%$2.15$1.9513,662 shs$2.76 million09/05/2024$2.18$2.06-5.50%$2.12$2.0610,770 shs$2.92 millionWar on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it.09/04/2024$2.12$2.18+2.83%$2.18$2.095,976 shs$3.09 million09/03/2024$2.15$2.12-1.40%$2.20$2.113,275 shs$4.73 million09/02/2024$2.15$2.15$2.20$2.125,100 shs$4.79 million08/30/2024$2.19$2.15-1.83%$2.20$2.125,191 shs$3.05 million08/29/2024$2.19$2.19$2.25$2.145,474 shs$3.10 million08/28/2024$2.24$2.19-2.23%$2.20$2.1310,946 shs$3.10 million08/27/2024$2.16$2.24+3.70%$2.24$2.175,266 shs$3.17 million08/26/2024$2.17$2.16-0.46%$2.24$2.161,108 shs$3.06 million08/23/2024$2.16$2.20+1.85%$2.25$2.204,139 shs$3.12 million08/22/2024$2.14$2.16+0.93%$2.34$2.1311,089 shs$3.06 million08/21/2024$2.21$2.14-3.17%$2.27$2.1027,626 shs$3.03 million08/20/2024$2.25$2.21-1.56%$2.23$2.144,216 shs$3.13 million08/19/2024$2.25$2.25-0.22%$2.30$2.217,616 shs$3.18 million08/16/2024$2.30$2.25-2.17%$2.33$2.228,244 shs$3.19 million08/15/2024$2.29$2.30+0.44%$2.37$2.215,672 shs$3.26 million08/14/2024$2.41$2.29-4.98%$2.45$2.196,185 shs$3.25 million08/13/2024$2.19$2.41+10.05%$2.43$2.1114,171 shs$3.42 million08/12/2024$2.14$2.19+2.34%$2.48$2.076,867 shs$3.10 million08/09/2024$2.20$2.14-2.73%$2.23$2.1418,958 shs$3.03 million08/08/2024$2.25$2.20-2.22%$2.47$2.2015,732 shs$3.12 million08/07/2024$2.34$2.25-3.85%$2.52$2.2512,997 shs$3.20 million08/06/2024$2.33$2.34+0.43%$2.40$2.267,015 shs$3.32 million08/05/2024$2.51$2.33-7.17%$2.50$2.2712,203 shs$3.31 million08/02/2024$2.57$2.50-2.72%$2.55$2.499,200 shs$3.55 million08/01/2024$2.61$2.57-1.53%$2.68$2.4822,201 shs$3.65 million07/31/2024$2.60$2.61+0.38%$2.73$2.5620,359 shs$3.71 million07/30/2024$2.74$2.60-5.11%$2.80$2.5324,107 shs$3.69 million Related Companies Jaguar Health Stock Price Chart Talphera Stock Price Chart Synlogic Stock Price Chart MIRA Pharmaceuticals Stock Price Chart Unicycive Therapeutics Stock Price Chart Kazia Therapeutics Stock Price Chart PharmaCyte Biotech Stock Price Chart Cara Therapeutics Stock Price Chart Indaptus Therapeutics Stock Price Chart IN8bio Stock Price Chart Receive GTBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GTBP) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GT Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
